The advantages and drawbacks clearly demonstrate the challenges involved in developing and applying PSMA-based probes for prostate cancer detection and treatment, emphasizing the imperative for sustained investigation and development [105]. The gene discussed is FOLH1; the disease is prostate carcinoma.